These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6870648)

  • 1. The controversial role of BCG in the treatment of squamous cell carcinoma of the head and neck.
    Medina JE
    Arch Otolaryngol; 1983 Aug; 109(8):543. PubMed ID: 6870648
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.
    Suen JY; Richman SP; Livingston RB; Hersh EM; Craig R; Tonymon K
    Am J Surg; 1977 Oct; 134(4):474-8. PubMed ID: 911030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized trial of adjuvant BCG immunotherapy in head and neck cancer.
    Taylor SG; Sisson GA; Bytell DE; Raynor WJ
    Arch Otolaryngol; 1983 Aug; 109(8):544-9. PubMed ID: 6347154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience in using the extract (SSM) from tubercle bacilli for patients with head and neck tumors (author's transl)].
    Sakai S; Yamamoto K; Suzuki S; Murata M
    Nihon Gan Chiryo Gakkai Shi; 1977 Sep; 12(3):321-7. PubMed ID: 915354
    [No Abstract]   [Full Text] [Related]  

  • 6. BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma.
    Sánchez-Rodríguez C; Cruces KP; Riestra Ayora J; Martín-Sanz E; Sanz-Fernández R
    Vaccine; 2017 Nov; 35(47):6395-6403. PubMed ID: 29029943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intratumor immunotherapy with BCG cell wall preparations: development of a new therapy approach for head-neck tumors].
    Bier J; Kleinschuster S; Bier H; Rapp H
    Arch Otorhinolaryngol; 1982; 236(3):245-55. PubMed ID: 7159277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy for head and neck squamous cell carcinoma].
    Chen J; Chen M; Wu HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 52(2):143-147. PubMed ID: 28219181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate plus Bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck.
    Donaldson RC
    Am J Surg; 1972 Oct; 124(4):527-34. PubMed ID: 5076168
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoimmunotherapy for cancer of the head and neck.
    Donaldson RC
    Am J Surg; 1973 Oct; 126(4):507-12. PubMed ID: 4743834
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemoimmunotherapy in advanced lesions of the head and neck.
    Eilber FR; Morton DL
    AJR Am J Roentgenol; 1976 May; 126(5):1082-7. PubMed ID: 178233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose methotrexate with and without BCG therapy in advanced head and neck malignancy.
    Buechler M; Mukherji B; Chasin W; Nathanson L
    Cancer; 1979 Mar; 43(3):1095-100. PubMed ID: 311679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of methotrexate and Bacillus Calmette-Guérin therapy for advanced head and neck cancer.
    Papac R; Minor DR; Rudnick S; Solomon LR; Capizzi RL
    Cancer Res; 1978 Oct; 38(10):3150-3. PubMed ID: 356962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell rosette test in squamous cell carcinoma of the head and neck.
    Eastham RJ; Mason JM; Jennings BR; Belew PW; Maguda TA
    Arch Otolaryngol; 1976 Mar; 102(3):171-5. PubMed ID: 1083730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma.
    Baxi SS; Dunn LA; Burtness BA
    Oral Oncol; 2016 Nov; 62():147-148. PubMed ID: 27776933
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of combined methotrexate, BCG, and INH therapy for squamous cell carcinoma of the head and neck.
    Woods JE; DeSanto LW; Ritts RE
    Surg Clin North Am; 1977 Aug; 57(4):769-78. PubMed ID: 897965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
    Hanna GJ; Adkins DR; Zolkind P; Uppaluri R
    Oral Oncol; 2017 Oct; 73():65-69. PubMed ID: 28939078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.